Connection
Ihab Kamel to Benzenesulfonates
This is a "connection" page, showing publications Ihab Kamel has written about Benzenesulfonates.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.023 |
|
|
|
-
Pawlik TM, Reyes DK, Cosgrove D, Kamel IR, Bhagat N, Geschwind JF. Phase II trial of sorafenib combined with concurrent transarterial chemoembolization with drug-eluting beads for hepatocellular carcinoma. J Clin Oncol. 2011 Oct 20; 29(30):3960-7.
Score: 0.023